Fundacion Clinic Per A La Recerca Biomédica
Clinical trials sponsored by Fundacion Clinic Per A La Recerca Biomédica, explained in plain language.
-
Pill power: oral antibiotics may match IVs for serious heart infection
Disease control Recruiting nowThis study compares oral antibiotics to intravenous (IV) antibiotics for treating infective endocarditis, a serious heart infection. Researchers want to see if taking pills at home works as well as getting IV treatment in a clinic. The trial involves 360 adults with specific type…
Phase: PHASE4 • Sponsor: Fundacion Clinic per a la Recerca Biomédica • Aim: Disease control
Last updated Jun 23, 2026 11:57 UTC
-
Could a simple injection cut blood transfusions in liver transplants?
Disease control Recruiting nowThis study tests if a drug called darbepoetin can lower the need for blood transfusions during liver transplant surgery. About 140 adults on the liver transplant waiting list with low hemoglobin will receive either the drug or a placebo. The goal is to see if the drug safely redu…
Phase: PHASE3 • Sponsor: Fundacion Clinic per a la Recerca Biomédica • Aim: Disease control
Last updated Jun 11, 2026 11:57 UTC
-
Could a dye-and-radiation combo spare ovarian cancer patients from extensive lymph node removal?
Diagnosis Recruiting nowThis study tests whether a combination of a radioactive tracer and a green dye can accurately identify the first lymph nodes that ovarian cancer may spread to. About 62 women with early-stage ovarian cancer will receive both tracers before surgery. If successful, this approach co…
Phase: NA • Sponsor: Fundacion Clinic per a la Recerca Biomédica • Aim: Diagnosis
Last updated Jun 15, 2026 18:54 UTC
-
Could a custom vaccine stop cancer before it starts in lynch syndrome?
Prevention Recruiting nowThis early-stage study tests a new vaccine made from a person's own immune cells to see if it can prevent cancer in people with Lynch syndrome, a genetic condition that raises cancer risk. The vaccine is designed to train the immune system to recognize and attack cells that might…
Phase: PHASE1 • Sponsor: Fundacion Clinic per a la Recerca Biomédica • Aim: Prevention
Last updated Jun 15, 2026 19:08 UTC